<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00932360</url>
  </required_header>
  <id_info>
    <org_study_id>200903744</org_study_id>
    <nct_id>NCT00932360</nct_id>
    <nct_alias>NCT00750321</nct_alias>
  </id_info>
  <brief_title>Transcutaneous Electrical Nerve Stimulation (TENS) and Fibromyalgia (FM)</brief_title>
  <acronym>TENS&amp;FM</acronym>
  <official_title>Transcutaneous Electrical Nerve Stimulation (TENS) and Fibromyalgia (FM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dana Dailey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Physical Therapy Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fibromyalgia as a clinical syndrome is defined by chronic widespread muscular pain, fatigue
      and tenderness with hyperalgesia to pressure over tender points. Pain associated with
      fibromyalgia can interfere with daily function, work, and social activities. Thus, one of the
      main treatments for patients with fibromyalgia must focus on pain relief to allow the person
      to function more independently both at home and at work. Although the etiology of
      fibromyalgia is unknown, there is clearly enhanced sensitization in the central nervous
      system pain pathways as demonstrating by decreases in pressure pain thresholds, reduced
      central inhibition, and enhanced temporal summation. Reducing pain in people with
      fibromyalgia would help increase the patient's ability to return to work, perform activities
      of daily living and thus improve the quality of life for the patient. Transcutaneous
      electrical nerve stimulation (TENS) is a modality utilized in physical therapy that delivers
      electrical stimulation through the skin and is used for both acute and chronic pain. TENS
      works by reducing central excitability and increasing central inhibition. Thus, the
      investigators hypothesize that application of Transcutaneous Electrical Nerve Stimulation
      (TENS) to patients with Fibromyalgia (FM) will reduce pain, reduce central excitability by
      restoring diffuse noxious inhibitory controls (DNIC), and reduce temporal summation and that
      this decrease in pain and/or central excitability will improve function. The primary aim of
      the study is to test the effectiveness of TENS on pain and central excitability in a
      crossover design study for patients with Fibromyalgia with random assignment to three
      treatments: no treatment control, placebo TENS and active high frequency TENS. A secondary
      aim is to test the effect of decreased pain and central excitability on function in patients
      with Fibromyalgia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be a simple crossover design with the following three treatments (1) active
      TENS, (2) placebo TENS or (3) no treatment control randomly assigned. Subjects will draw the
      order for treatments (A, B, and C) out of a bowl at the initial testing session. This will
      determine the order of the testing. Each subject will receive all 3 treatments in random
      order.

      The following tools will be used to measure subject characteristics (Fibromyalgia Impact
      Questionnaire, Tampa Scale of Kinesiophobia), pain (McGill Pain Questionnaire and Visual
      Analogue Scale), central excitability (pressure pain thresholds, temporal summation and DNIC)
      and function (6 minute walk test, range of motion, sit to stand test).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain at Rest Difference Score Pre-intervention and Post Intervention</measure>
    <time_frame>3 weeks</time_frame>
    <description>Visual Analog Scale 0-10 with 0 No Pain and 10 Worst Pain Imaginable Pain was measured at rest before and after intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain With Movement Difference Score Pre-intervention and Post Intervention</measure>
    <time_frame>3 weeks</time_frame>
    <description>Visual Analog Scale 0-10 with 0 No Pain and 10 Worst Pain Imaginable Pain was measured at rest before and after intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fatigue at Rest Difference Score Pre-intervention and Post Intervention</measure>
    <time_frame>3 weeks</time_frame>
    <description>Visual Analog Scale 0-10 with 0 No Fatigue and 10 Worst Fatigue Imaginable Pain was measured at rest before and after intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue With Movement Difference Score Pre-intervention and Post Intervention</measure>
    <time_frame>3 weeks</time_frame>
    <description>Visual Analog Scale 0-10 with 0 No Fatigue and 10 Worst Fatigue Imaginable Pain was measured at rest before and after intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PPT Cervical Region</measure>
    <time_frame>3 weeks</time_frame>
    <description>Pressure pain threshold cervical region (kPa)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PPT Lumbar Region</measure>
    <time_frame>3 weeks</time_frame>
    <description>Pressure pain threshold in lumbar region (kPa)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PPT for Anterior Tibialis</measure>
    <time_frame>3 weeks</time_frame>
    <description>Pressure pain threshold in leg (kPa)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 Minute Walk Test Average Change (Feet)</measure>
    <time_frame>3 weeks</time_frame>
    <description>6 minute walk test average change (feet) before and after intervention</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>Active TENS Placebo TENS No TENS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active TENS: 100 Hz, 200 μs at maximal tolerable intensity Placebo TENS: 100 Hz, 200 μs on for 45 seconds and then ramped off No TENS: Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo TENS Active TENS No TENS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo TENS: 100 Hz, 200 μs on for 45 seconds and then ramped off Active TENS: 100 Hz, 200 μs at maximal tolerable intensity Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No TENS Active TENS Placebo TENS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No TENS: Participants wore a TENS unit that was turned off for blinding of the outcome assessor Active TENS: 100 Hz, 200 μs at maximal tolerable intensity Placebo TENS: 100 Hz, 200 μs on for 45 seconds and then ramped off</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active TENS No TENS Placebo TENS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active TENS: 100 Hz, 200 μs at maximal tolerable intensity No TENS: Participants wore a TENS unit that was turned off for blinding of the outcome assessor Placebo TENS: 100 Hz, 200 μs on for 45 seconds and then ramped off</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo TENS No TENS Active TENS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo TENS: 100 Hz, 200 μs on for 45 seconds and then ramped off Participants wore a TENS unit that was turned off for blinding of the outcome assessor Active TENS: 100 Hz, 200 μs at maximal tolerable intensity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No TENS Placebo TENS Active TENS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No TENS: Participants wore a TENS unit that was turned off for blinding of the outcome assessor Placebo TENS: 100 Hz, 200 μs on for 45 seconds and then ramped off Active TENS: 100 Hz, 200 μs at maximal tolerable intensity</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TENS</intervention_name>
    <description>Active TENS, Placebo TENS and No Treatment TENS</description>
    <arm_group_label>Active TENS No TENS Placebo TENS</arm_group_label>
    <arm_group_label>Active TENS Placebo TENS No TENS</arm_group_label>
    <arm_group_label>No TENS Active TENS Placebo TENS</arm_group_label>
    <arm_group_label>No TENS Placebo TENS Active TENS</arm_group_label>
    <arm_group_label>Placebo TENS Active TENS No TENS</arm_group_label>
    <arm_group_label>Placebo TENS No TENS Active TENS</arm_group_label>
    <other_name>Rehabilicare Maxima</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fibromyalgia diagnosis by a physician

          -  History of cervical or lumbar pain

        Exclusion Criteria:

          -  TENS use in the last 5 years

          -  Pacemaker

          -  No use of opioids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana L Dailey, PT,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kathleen A Sluka, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Barbara Rakel, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Iowa - Physical Therapy and Rehabilitation Science</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www-ncbi-nlm-nih-gov.proxy.lib.uiowa.edu/pmc/articles/PMC3972497/</url>
    <description>PubMed Link for full text article</description>
  </link>
  <results_reference>
    <citation>Dailey DL, Rakel BA, Vance CG, Liebano RE, Amrit AS, Bush HM, Lee KS, Lee JE, Sluka KA. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain. 2013 Nov;154(11):2554-62. doi: 10.1016/j.pain.2013.07.043. Epub 2013 Jul 27.</citation>
    <PMID>23900134</PMID>
  </results_reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>June 23, 2009</study_first_submitted>
  <study_first_submitted_qc>July 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2009</study_first_posted>
  <results_first_submitted>March 28, 2017</results_first_submitted>
  <results_first_submitted_qc>January 9, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">January 10, 2019</results_first_posted>
  <last_update_submitted>January 14, 2019</last_update_submitted>
  <last_update_submitted_qc>January 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Dana Dailey</investigator_full_name>
    <investigator_title>Research Associate</investigator_title>
  </responsible_party>
  <keyword>Fibromyalgia</keyword>
  <keyword>Transcutaneous Electrical Nerve Stimulation (TENS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>See Publication listed for data</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects (125) were screened for eligibility via telephone. 82 were excluded and 43 were consented and enrolled at the University of Iowa</recruitment_details>
      <pre_assignment_details>43 subjects were consented and enrolled to the cross over design study. Subjects were randomized to treatment group order after providing written consent. The three treatment groups for randomization order included: active TENS, placebo TENS and no treatment TENS.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Active TENS, Placebo TENS and No TENS</title>
          <description>Active TENS: 100 Hz, 200 μs at maximal tolerable intensity Placebo TENS:TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame No TENS: Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
        </group>
        <group group_id="P2">
          <title>Active TENS No TENS Placebo TENS</title>
          <description>Active TENS: 100 Hz, 200 μs at maximal tolerable intensity Placebo TENS:TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame No TENS: Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
        </group>
        <group group_id="P3">
          <title>Placebo TENS Active TENS No TENS</title>
          <description>Active TENS: 100 Hz, 200 μs at maximal tolerable intensity Placebo TENS:TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame No TENS: Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
        </group>
        <group group_id="P4">
          <title>Placebo TENS No TENS Active TENS</title>
          <description>Active TENS: 100 Hz, 200 μs at maximal tolerable intensity Placebo TENS:TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame No TENS: Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
        </group>
        <group group_id="P5">
          <title>No TENS Active TENS Placebo TENS</title>
          <description>Active TENS: 100 Hz, 200 μs at maximal tolerable intensity Placebo TENS:TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame No TENS: Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
        </group>
        <group group_id="P6">
          <title>No TENS Placebo TENS Active TENS</title>
          <description>Active TENS: 100 Hz, 200 μs at maximal tolerable intensity Placebo TENS:TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame No TENS: Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>1: Visit 1/Week1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="13"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="13"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout (One Week)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="13"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="13"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Visit 2/Week 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="13"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="13"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout (One Week)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="13"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="13"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Visit 3/Week 3</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="13"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="13"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>This is a crossover study with three groups. Subjects completed each arm of the study in random order.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="43"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <population>2 subjects withdrew from the study after the first visit</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <population>2 subjects withdrew after 1 visit</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain at Rest Difference Score Pre-intervention and Post Intervention</title>
        <description>Visual Analog Scale 0-10 with 0 No Pain and 10 Worst Pain Imaginable Pain was measured at rest before and after intervention.</description>
        <time_frame>3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active TENS</title>
            <description>Active and Placebo TENS with configured Rehabilicare Unit; No TENS with TENS worn and not turned on.</description>
          </group>
          <group group_id="O2">
            <title>Placebo TENS</title>
            <description>Active and Placebo TENS with configured Rehabilicare Unit; No TENS with TENS worn and not turned on.</description>
          </group>
          <group group_id="O3">
            <title>No TENS</title>
            <description>Active and Placebo TENS with configured Rehabilicare Unit; No TENS with TENS worn and not turned on.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at Rest Difference Score Pre-intervention and Post Intervention</title>
          <description>Visual Analog Scale 0-10 with 0 No Pain and 10 Worst Pain Imaginable Pain was measured at rest before and after intervention.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.38" spread="0.26"/>
                    <measurement group_id="O2" value="-0.74" spread="0.25"/>
                    <measurement group_id="O3" value="-0.47" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain With Movement Difference Score Pre-intervention and Post Intervention</title>
        <description>Visual Analog Scale 0-10 with 0 No Pain and 10 Worst Pain Imaginable Pain was measured at rest before and after intervention.</description>
        <time_frame>3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active TENS to No Treatment to Placebo (ANP)</title>
            <description>Active and Placebo TENS with configured Rehabilicare Unit; No TENS with TENS worn and not turned on.</description>
          </group>
          <group group_id="O2">
            <title>Active TENS to Placebo to No Treatment (APN)</title>
            <description>Active and Placebo TENS with configured Rehabilicare Unit; No TENS with TENS worn and not turned on.</description>
          </group>
          <group group_id="O3">
            <title>No Treatment to Active TENS to Placebo TENS (NAP)</title>
            <description>Active and Placebo TENS with configured Rehabilicare Unit; No TENS with TENS worn and not turned on.r</description>
          </group>
        </group_list>
        <measure>
          <title>Pain With Movement Difference Score Pre-intervention and Post Intervention</title>
          <description>Visual Analog Scale 0-10 with 0 No Pain and 10 Worst Pain Imaginable Pain was measured at rest before and after intervention.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.11" spread="0.26"/>
                    <measurement group_id="O2" value="0.23" spread="0.26"/>
                    <measurement group_id="O3" value="0.26" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fatigue at Rest Difference Score Pre-intervention and Post Intervention</title>
        <description>Visual Analog Scale 0-10 with 0 No Fatigue and 10 Worst Fatigue Imaginable Pain was measured at rest before and after intervention.</description>
        <time_frame>3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active TENS</title>
            <description>100 Hz, 200 μs at maximal tolerable intensity</description>
          </group>
          <group group_id="O2">
            <title>Placebo TENS</title>
            <description>TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame</description>
          </group>
          <group group_id="O3">
            <title>No TENS</title>
            <description>Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
          </group>
        </group_list>
        <measure>
          <title>Fatigue at Rest Difference Score Pre-intervention and Post Intervention</title>
          <description>Visual Analog Scale 0-10 with 0 No Fatigue and 10 Worst Fatigue Imaginable Pain was measured at rest before and after intervention.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="0.21"/>
                    <measurement group_id="O2" value="-0.14" spread="0.21"/>
                    <measurement group_id="O3" value="0.12" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fatigue With Movement Difference Score Pre-intervention and Post Intervention</title>
        <description>Visual Analog Scale 0-10 with 0 No Fatigue and 10 Worst Fatigue Imaginable Pain was measured at rest before and after intervention.</description>
        <time_frame>3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active TENS</title>
            <description>100 Hz, 200 μs at maximal tolerable intensity</description>
          </group>
          <group group_id="O2">
            <title>Placebo TENS</title>
            <description>TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame</description>
          </group>
          <group group_id="O3">
            <title>No TENS</title>
            <description>Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
          </group>
        </group_list>
        <measure>
          <title>Fatigue With Movement Difference Score Pre-intervention and Post Intervention</title>
          <description>Visual Analog Scale 0-10 with 0 No Fatigue and 10 Worst Fatigue Imaginable Pain was measured at rest before and after intervention.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.94" spread="0.23"/>
                    <measurement group_id="O2" value="0.39" spread="0.24"/>
                    <measurement group_id="O3" value="0.04" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PPT Cervical Region</title>
        <description>Pressure pain threshold cervical region (kPa)</description>
        <time_frame>3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active TENS</title>
            <description>100 Hz, 200 μs at maximal tolerable intensity</description>
          </group>
          <group group_id="O2">
            <title>Placebo TENS</title>
            <description>TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame</description>
          </group>
          <group group_id="O3">
            <title>No TENS</title>
            <description>Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
          </group>
        </group_list>
        <measure>
          <title>PPT Cervical Region</title>
          <description>Pressure pain threshold cervical region (kPa)</description>
          <units>pressure score (kPa)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.15" spread="10.09"/>
                    <measurement group_id="O2" value="26.42" spread="10.02"/>
                    <measurement group_id="O3" value="19.39" spread="10.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PPT Lumbar Region</title>
        <description>Pressure pain threshold in lumbar region (kPa)</description>
        <time_frame>3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active TENS</title>
            <description>100 Hz, 200 μs at maximal tolerable intensity</description>
          </group>
          <group group_id="O2">
            <title>Placebo TENS</title>
            <description>TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame</description>
          </group>
          <group group_id="O3">
            <title>No TENS</title>
            <description>Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
          </group>
        </group_list>
        <measure>
          <title>PPT Lumbar Region</title>
          <description>Pressure pain threshold in lumbar region (kPa)</description>
          <units>pressure score (kPa)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.97" spread="15.97"/>
                    <measurement group_id="O2" value="34.89" spread="15.91"/>
                    <measurement group_id="O3" value="33.23" spread="15.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PPT for Anterior Tibialis</title>
        <description>Pressure pain threshold in leg (kPa)</description>
        <time_frame>3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active TENS</title>
            <description>100 Hz, 200 μs at maximal tolerable intensity</description>
          </group>
          <group group_id="O2">
            <title>Placebo TENS</title>
            <description>TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame</description>
          </group>
          <group group_id="O3">
            <title>No TENS</title>
            <description>Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
          </group>
        </group_list>
        <measure>
          <title>PPT for Anterior Tibialis</title>
          <description>Pressure pain threshold in leg (kPa)</description>
          <units>pressure score (kPa)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.86" spread="18.34"/>
                    <measurement group_id="O2" value="38.98" spread="21.85"/>
                    <measurement group_id="O3" value="4.4" spread="15.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>6 Minute Walk Test Average Change (Feet)</title>
        <description>6 minute walk test average change (feet) before and after intervention</description>
        <time_frame>3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active TENS</title>
            <description>100 Hz, 200 μs at maximal tolerable intensity</description>
          </group>
          <group group_id="O2">
            <title>Placebo TENS</title>
            <description>TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame</description>
          </group>
          <group group_id="O3">
            <title>No TENS</title>
            <description>Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
          </group>
        </group_list>
        <measure>
          <title>6 Minute Walk Test Average Change (Feet)</title>
          <description>6 minute walk test average change (feet) before and after intervention</description>
          <units>feet</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="43"/>
                <count group_id="O3" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.85" spread="36.7"/>
                    <measurement group_id="O2" value="-40.48" spread="36.31"/>
                    <measurement group_id="O3" value="-0.97" spread="36.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Active TENS</title>
          <description>100 Hz, 200 μs at maximal tolerable intensity</description>
        </group>
        <group group_id="E2">
          <title>Placebo TENS</title>
          <description>TENS at 100 Hz, 200 μs for 30 seconds and then the current ramped off over a 15 second time frame</description>
        </group>
        <group group_id="E3">
          <title>No TENS</title>
          <description>Participants wore a TENS unit that was turned off for blinding of the outcome assessor</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="43"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>43 subjects were enrolled to the study and completed a treatment (Active TENS, Placebo TENS or No TENS) in a randomized order with a one week washout period between treatments. Results were analyzed by comparing the groups for outcome measures.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dana Dailey</name_or_title>
      <organization>University of Iowa</organization>
      <phone>319-335-7149</phone>
      <email>dana-dailey@uiowa.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

